278 results on '"Obeid LM"'
Search Results
2. GOLPH3 promotes oncogenesis by controlling the intra-Golgi trafficking of glycosphingolipid synthases
- Author
-
Rizzo, Riccardo, Russo, Domenico, Kurokawa, Kazuo, Domenico Supino, Sahu, Pranoy, Lombardi, Bernadette, Russo, Francesco, Zhukovsky, Mikhail, Barros, Monica Gracia, Pothukuchi, Prathyush, Sticco, Lucia, Capasso, Serena, Capolupo, Laura, Boncompain, Gaelle, Dathan, Nina, Turacchio, Gabriele, Zito Marino, Federica, Acquino, Gabriella, Vitagliano, Carlo, Henklein, Petra, Clausen, Henrik, Mandel, Ulla, Yamaji, Toshiyuki, Hanada, Kentaro, Budillon, Alfredo, Parashuraman, Seetharaman, Perez, Franck, Obeid, Lina M., Nakano, Aki, Hannun, Yusuf A., Luini, Alberto, D Angelo, Giovanni, Rizzo, R, Russo, D, Kurokawa, K, Supino, D, Sahu, P, Lombardi, B, Russo, F, Zhukovsky, M, Barros, Mg, Pothukuchi, P, Sticco, L, Capasso, S, Capolupo, L, Boncompain, G, Dathan, N, Turacchio, G, Zito Marino, F, Acquino, G, Vitagliano, C, Henklein, P, Clausen, H, Mandel, U, Yamaji, T, Hanada, K, Budillon, A, Parashuraman, S, Perez, F, Obeid, Lm, Nakano, A, Hannun, Ya, Luini, A, and D'Angelo, G
3. Expression of Ceramide Synthases in Mice and Their Roles in Regulating Acyl-Chain Sphingolipids: A Framework for Baseline Levels and Future Implications in Aging and Disease.
- Author
-
Richardson WJ, Humphrey SB, Sears SM, Hoffman NA, Orwick AJ, Doll MA, Doll CL, Xia C, Hernandez-Corbacho M, Snider JM, Obeid LM, Hannun YA, Snider AJ, and Siskind LJ
- Subjects
- Mice, Animals, Humans, Infant, Mice, Inbred C57BL, Protein Isoforms, Aging genetics, RNA, Messenger genetics, RNA, Messenger metabolism, Sphingolipids genetics, Sphingolipids metabolism, Ceramides genetics, Ceramides metabolism, Oxidoreductases
- Abstract
Sphingolipids are an important class of lipids present in all eukaryotic cells that regulate critical cellular processes. Disturbances in sphingolipid homeostasis have been linked to several diseases in humans. Ceramides are central in sphingolipid metabolism and are largely synthesized by six ceramide synthase (CerS) isoforms (CerS1-6), each with a preference for different fatty acyl chain lengths. Although the tissue distribution of CerS mRNA expression in humans and the roles of CerS isoforms in synthesizing ceramides with different acyl chain lengths are known, it is unknown how CerS expression dictates ceramides and downstream metabolites within tissues. In this study, we analyzed sphingolipid levels and CerS mRNA expression in 3-month-old C57BL/6J mouse brain, heart, kidney, liver, lung, and skeletal muscle. The results showed that CerS expression and sphingolipid species abundance varied by tissue and that CerS expression was a predictor of ceramide species within tissues. Interestingly, although CerS expression was not predictive of complex sphingolipid species within all tissues, composite scores for CerSs contributions to total sphingolipids measured in each tissue correlated to CerS expression. Lastly, we determined that the most abundant ceramide species in mouse tissues aligned with CerS mRNA expression in corresponding human tissues (based on chain length preference), suggesting that mice are relevant preclinical models for ceramide and sphingolipid research. SIGNIFICANCE STATEMENT: The current study demonstrates that ceramide synthase (CerS) expression in specific tissues correlates not only with ceramide species but contributes to the generation of complex sphingolipids as well. As many of the CerSs and/or specific ceramide species have been implicated in disease, these studies suggest the potential for CerSs as therapeutic targets and the use of sphingolipid species as diagnostics in specific tissues., (U.S. Government work not protected by U.S. copyright.)
- Published
- 2024
- Full Text
- View/download PDF
4. A novel HSPB1 S139F mouse model of Charcot-Marie-Tooth Disease.
- Author
-
Espinoza KS, Hermanson KN, Beard CA, Schwartz NU, Snider JM, Low BE, Wiles MV, Hannun YA, Obeid LM, and Snider AJ
- Subjects
- Mice, Animals, Heat-Shock Proteins genetics, Mutation genetics, Disease Models, Animal, Sphingolipids, Charcot-Marie-Tooth Disease genetics, Charcot-Marie-Tooth Disease pathology
- Abstract
Charcot-Marie-Tooth Disease (CMT) is a commonly inherited peripheral polyneuropathy. Clinical manifestations for this disease include symmetrical distal polyneuropathy, altered deep tendon reflexes, distal sensory loss, foot deformities, and gait abnormalities. Genetic mutations in heat shock proteins have been linked to CMT2. Specifically, mutations in the heat shock protein B1 (HSPB1) gene encoding for heat shock protein 27 (Hsp27) have been linked to CMT2F and distal hereditary motor and sensory neuropathy type 2B (dHMSN2B) subtype. The goal of the study was to examine the role of an endogenous mutation in HSPB1 in vivo and to define the effects of this mutation on motor function and pathology in a novel animal model. As sphingolipids have been implicated in hereditary and sensory neuropathies, we examined sphingolipid metabolism in central and peripheral nervous tissues in 3-month-old Hsp
S139F mice. Though sphingolipid levels were not altered in sciatic nerves from HspS139F mice, ceramides and deoxyceramides, as well as sphingomyelins (SMs) were elevated in brain tissues from HspS139F mice. Histology was utilized to further characterize HspS139F mice. HspS139F mice exhibited no alterations to the expression and phosphorylation of neurofilaments, or in the expression of acetylated α-tubulin in the brain or sciatic nerve. Interestingly, HspS139F mice demonstrated cerebellar demyelination. Locomotor function, grip strength and gait were examined to define the role of HspS139F in the clinical phenotypes associated with CMT2F. Gait analysis revealed no differences between HspWT and HspS139F mice. However, both coordination and grip strength were decreased in 3-month-old HspS139F mice. Together these data suggest that the endogenous S139F mutation in HSPB1 may serve as a mouse model for hereditary and sensory neuropathies such as CMT2F., Competing Interests: Disclosures All authors declare that they have no conflicts of interest., (Copyright © 2023 Elsevier Inc. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
5. Targeting sphingosine kinase 1 in p53KO thymic lymphoma.
- Author
-
Velazquez FN, Stith JL, Zhang L, Allam AM, Haley J, Obeid LM, Snider AJ, and Hannun YA
- Subjects
- Animals, Mice, Sphingosine metabolism, Phosphotransferases (Alcohol Group Acceptor) metabolism, Tumor Suppressor Protein p53 genetics, Tumor Suppressor Protein p53 metabolism, Neoplasms metabolism
- Abstract
Sphingosine kinase 1 (SK1) is a key sphingolipid enzyme that is upregulated in several types of cancer, including lymphoma which is a heterogenous group of malignancies. Treatment for lymphoma has improved significantly by the introduction of new therapies; however, subtypes with tumor protein P53 (p53) mutations or deletion have poor prognosis, making it critical to explore new therapeutic strategies in this context. SK1 has been proposed as a therapeutic target in different types of cancer; however, the effect of targeting SK1 in cancers with p53 deletion has not been evaluated yet. Previous work from our group suggests that loss of SK1 is a key event in mediating the tumor suppressive effect of p53. Employing both genetic and pharmacological approaches to inhibit SK1 function in Trp53KO mice, we show that targeting SK1 decreases tumor growth of established p53KO thymic lymphoma. Inducible deletion of Sphk1 or its pharmacological inhibition drive increased cell death in tumors which is accompanied by selective accumulation of sphingosine levels. These results demonstrate the relevance of SK1 in the growth and maintenance of lymphoma in the absence of p53 function, positioning this enzyme as a potential therapeutic target for the treatment of tumors that lack functional p53., (© 2023 Federation of American Societies for Experimental Biology.)
- Published
- 2023
- Full Text
- View/download PDF
6. The heat shock protein Hsp27 controls mitochondrial function by modulating ceramide generation.
- Author
-
Boyd RA, Majumder S, Stiban J, Mavodza G, Straus AJ, Kempelingaiah SK, Reddy V, Hannun YA, Obeid LM, and Senkal CE
- Subjects
- Mitochondria metabolism, Mitophagy, Sphingolipids metabolism, Humans, Ceramides metabolism, HSP27 Heat-Shock Proteins genetics
- Abstract
Sphingolipids have key functions in membrane structure and cellular signaling. Ceramide is the central molecule of the sphingolipid metabolism and is generated by ceramide synthases (CerS) in the de novo pathway. Despite their critical function, mechanisms regulating CerS remain largely unknown. Using an unbiased proteomics approach, we find that the small heat shock protein 27 (Hsp27) interacts specifically with CerS1 but not other CerS. Functionally, our data show that Hsp27 acts as an endogenous inhibitor of CerS1. Wild-type Hsp27, but not a mutant deficient in CerS1 binding, inhibits CerS1 activity. Additionally, silencing of Hsp27 enhances CerS1-generated ceramide accumulation in cells. Moreover, phosphorylation of Hsp27 modulates Hsp27-CerS1 interaction and CerS1 activity in acute stress-response conditions. Biologically, we show that Hsp27 knockdown impedes mitochondrial function and induces lethal mitophagy in a CerS1-dependent manner. Overall, we identify an important mode of CerS1 regulation and CerS1-mediated mitophagy through protein-protein interaction with Hsp27., Competing Interests: Declaration of interests The authors declare no competing interests., (Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
7. Ceramide as an endothelial cell surface receptor and a lung-specific lipid vascular target for circulating ligands.
- Author
-
Staquicini DI, Cardó-Vila M, Rotolo JA, Staquicini FI, Tang FHF, Smith TL, Ganju A, Schiavone C, Dogra P, Wang Z, Cristini V, Giordano RJ, Ozawa MG, Driessen WHP, Proneth B, Souza GR, Brinker LM, Noureddine A, Snider AJ, Canals D, Gelovani JG, Petrache I, Tuder RM, Obeid LM, Hannun YA, Kolesnick RN, Brinker CJ, Pasqualini R, and Arap W
- Subjects
- Humans, Ligands, Ceramides metabolism, Lung metabolism, Endothelium, Vascular metabolism, Receptors, Cell Surface metabolism, Carrier Proteins metabolism, Sphingomyelin Phosphodiesterase metabolism, COVID-19 metabolism
- Abstract
The vascular endothelium from individual organs is functionally specialized, and it displays a unique set of accessible molecular targets. These serve as endothelial cell receptors to affinity ligands. To date, all identified vascular receptors have been proteins. Here, we show that an endothelial lung-homing peptide (CGSPGWVRC) interacts with C16-ceramide, a bioactive sphingolipid that mediates several biological functions. Upon binding to cell surfaces, CGSPGWVRC triggers ceramide-rich platform formation, activates acid sphingomyelinase and ceramide production, without the associated downstream apoptotic signaling. We also show that the lung selectivity of CGSPGWVRC homing peptide is dependent on ceramide production in vivo. Finally, we demonstrate two potential applications for this lipid vascular targeting system: i) as a bioinorganic hydrogel for pulmonary imaging and ii) as a ligand-directed lung immunization tool against COVID-19. Thus, C16-ceramide is a unique example of a lipid-based receptor system in the lung vascular endothelium targeted in vivo by circulating ligands such as CGSPGWVRC.
- Published
- 2023
- Full Text
- View/download PDF
8. ACSL1 is a key regulator of inflammatory and macrophage foaming induced by short-term palmitate exposure or acute high-fat feeding.
- Author
-
Al-Rashed F, Haddad D, Al Madhoun A, Sindhu S, Jacob T, Kochumon S, Obeid LM, Al-Mulla F, Hannun YA, and Ahmad R
- Abstract
Foamy and inflammatory macrophages play pathogenic roles in metabolic disorders. However, the mechanisms that promote foamy and inflammatory macrophage phenotypes under acute-high-fat feeding (AHFF) remain elusive. Herein, we investigated the role of acyl-CoA synthetase-1 (ACSL1) in favoring the foamy/inflammatory phenotype of monocytes/macrophages upon short-term exposure to palmitate or AHFF. Palmitate exposure induced a foamy/inflammatory phenotype in macrophages which was associated with increased ACSL1 expression. Inhibition/knockdown of ACSL1 in macrophages suppressed the foamy/inflammatory phenotype through the inhibition of the CD36-FABP4-p38-PPARδ signaling axis. ACSL1 inhibition/knockdown suppressed macrophage foaming/inflammation after palmitate stimulation by downregulating the FABP4 expression. Similar results were obtained using primary human monocytes. As expected, oral administration of ACSL1 inhibitor triacsin-C in mice before AHFF normalized the inflammatory/foamy phenotype of the circulatory monocytes by suppressing FABP4 expression. Our results reveal that targeting ACSL1 leads to the attenuation of the CD36-FABP4-p38-PPARδ signaling axis, providing a therapeutic strategy to prevent the AHFF-induced macrophage foaming and inflammation., Competing Interests: The authors declare that they have no competing interests., (© 2023 The Author(s).)
- Published
- 2023
- Full Text
- View/download PDF
9. Upregulation of sphingosine kinase 1 in response to doxorubicin generates an angiogenic response via stabilization of Snail.
- Author
-
Bonica J, Clarke CJ, Obeid LM, Luberto C, and Hannun YA
- Subjects
- Humans, Up-Regulation, Phosphotransferases (Alcohol Group Acceptor) metabolism, Sphingolipids, Doxorubicin pharmacology, Sphingosine pharmacology, Sphingosine metabolism, Lysophospholipids pharmacology, Tumor Suppressor Protein p53 metabolism, Neoplasms
- Abstract
Sphingosine kinase 1 (SK1) converts the pro-death lipid sphingosine to the pro-survival sphingosine-1-phosphate (S1P) and is upregulated in several cancers. DNA damaging agents, such as the chemotherapeutic doxorubicin (Dox), have been shown to degrade SK1 protein in cancer cells, a process dependent on wild-type p53. As mutations in p53 are very common across several types of cancer, we evaluated the effects of Dox on SK1 in p53 mutant cancer cells. In the p53 mutant breast cancer cell line MDA-MB-231, we show that Dox treatment significantly increases SK1 protein and S1P. Using MDA-MB-231 cells with CRISPR-mediated knockout of SK1 or the selective SK1 inhibitor PF-543, we implicated SK1 in both Dox-induced migration and in a newly uncovered proangiogenic program induced by Dox. Mechanistically, inhibition of SK1 suppressed the induction of the cytokine BMP4 and of the EMT transcription factor Snail in response to Dox. Interestingly, induction of BMP4 by SK1 increased Snail levels following Dox treatment by stabilizing Snail protein. Furthermore, we found that SK1 was required for Dox-induced p38 MAP kinase phosphorylation and that active p38 MAPK in turn upregulated BMP4 and Snail, positioning p38 downstream of SK1 and upstream of BMP4/Snail. Modulating production of S1P by inhibition of de novo sphingolipid synthesis or knockdown of the S1P-degrading enzyme S1P lyase identified S1P as the sphingolipid activator of p38 in this model. This work establishes a novel angiogenic pathway in response to a commonly utilized chemotherapeutic and highlights the potential of SK1 as a secondary drug target for patients with p53 mutant cancer., (© 2023 Federation of American Societies for Experimental Biology.)
- Published
- 2023
- Full Text
- View/download PDF
10. Alkaline ceramidase catalyzes the hydrolysis of ceramides via a catalytic mechanism shared by Zn2+-dependent amidases.
- Author
-
Yi JK, Xu R, Obeid LM, Hannun YA, Airola MV, and Mao C
- Subjects
- Amidohydrolases genetics, Amidohydrolases metabolism, Ceramidases metabolism, Humans, Hydrolysis, Zinc metabolism, Alkaline Ceramidase genetics, Ceramides metabolism
- Abstract
Human alkaline ceramidase 3 (ACER3) is one of three alkaline ceramidases (ACERs) that catalyze the conversion of ceramide to sphingosine. ACERs are members of the CREST superfamily of integral-membrane hydrolases. All CREST members conserve a set of three Histidine, one Aspartate, and one Serine residue. Although the structure of ACER3 was recently reported, catalytic roles for these residues have not been biochemically tested. Here, we use ACER3 as a prototype enzyme to gain insight into this unique class of enzymes. Recombinant ACER3 was expressed in yeast mutant cells that lack endogenous ceramidase activity, and microsomes were used for biochemical characterization. Six-point mutants of the conserved CREST motif were developed that form a Zn-binding active site based on a recent crystal structure of human ACER3. Five point mutants completely lost their activity, with the exception of S77A, which showed a 600-fold decrease compared with the wild-type enzyme. The activity of S77C mutant was pH sensitive, with neutral pH partially recovering ACER3 activity. This suggested a role for S77 in stabilizing the oxyanion of the transition state. Together, these data indicate that ACER3 is a Zn2+-dependent amidase that catalyzes hydrolysis of ceramides via a similar mechanism to other soluble Zn-based amidases. Consistent with this notion, ACER3 was specifically inhibited by trichostatin A, a strong zinc chelator., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2022
- Full Text
- View/download PDF
11. Neutral ceramidase deficiency protects against cisplatin-induced acute kidney injury.
- Author
-
Sears SM, Dupre TV, Shah PP, Davis DL, Doll MA, Sharp CN, Vega AA, Megyesi J, Beverly LJ, Snider AJ, Obeid LM, Hannun YA, and Siskind LJ
- Subjects
- Animals, Apoptosis physiology, Cisplatin adverse effects, Fibroblasts metabolism, Humans, Mice, Neutral Ceramidase metabolism, Acute Kidney Injury chemically induced, Acute Kidney Injury prevention & control, Farber Lipogranulomatosis
- Abstract
Cisplatin is a commonly used chemotherapeutic for the treatment of many solid organ cancers; however, its effectiveness is limited by the development of acute kidney injury (AKI) in 30% of patients. AKI is driven by proximal tubule cell death, leading to rapid decline in renal function. It has previously been shown that sphingolipid metabolism plays a role in regulating many of the biological processes involved in cisplatin-induced AKI. For example, neutral ceramidase (nCDase) is an enzyme responsible for converting ceramide into sphingosine, which is then phosphorylated to become sphingosine-1-phosphate, and our lab previously demonstrated that nCDase knockout (nCDase-/-) in mouse embryonic fibroblasts led to resistance to nutrient and energy deprivation-induced cell death via upregulation of autophagic flux. In this study, we further characterized the role of nCDase in AKI by demonstrating that nCDase-/- mice are resistant to cisplatin-induced AKI. nCDase-/- mice display improved kidney function, reduced injury and structural damage, lower rates of apoptosis, and less ER stress compared to wild-type mice following cisplatin treatment. Although the mechanism of protection is still unknown, we propose that it could be mediated by increased autophagy, as chloroquine treatment resensitized nCDase-/- mice to AKI development. Taken together, we conclude that nCDase may represent a novel target to prevent cisplatin-induced nephrotoxicity., Competing Interests: Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article., (Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
12. 1-Deoxysphinganine initiates adaptive responses to serine and glycine starvation in cancer cells via proteolysis of sphingosine kinase.
- Author
-
Truman JP, Ruiz CF, Montal E, Garcia-Barros M, Mileva I, Snider AJ, Hannun YA, Obeid LM, and Mao C
- Subjects
- Humans, Animals, Proteolysis drug effects, Mice, Cell Line, Tumor, Neoplasms metabolism, Neoplasms pathology, Sphingolipids, Serine metabolism, Phosphotransferases (Alcohol Group Acceptor) metabolism, Sphingosine analogs & derivatives, Sphingosine metabolism, Glycine analogs & derivatives, Glycine pharmacology, Glycine metabolism
- Abstract
Cancer cells may depend on exogenous serine, depletion of which results in slower growth and activation of adaptive metabolic changes. We previously demonstrated that serine and glycine (SG) deprivation causes loss of sphingosine kinase 1 (SK1) in cancer cells, thereby increasing the levels of its lipid substrate, sphingosine (Sph), which mediates several adaptive biological responses. However, the signaling molecules regulating SK1 and Sph levels in response to SG deprivation have yet to be defined. Here, we identify 1-deoxysphinganine (dSA), a noncanonical sphingoid base generated in the absence of serine from the alternative condensation of alanine and palmitoyl CoA by serine palmitoyl transferase, as a proximal mediator of SG deprivation in SK1 loss and Sph level elevation upon SG deprivation in cancer cells. SG starvation increased dSA levels in vitro and in vivo and in turn induced SK1 degradation through a serine palmitoyl transferase-dependent mechanism, thereby increasing Sph levels. Addition of exogenous dSA caused a moderate increase in intracellular reactive oxygen species, which in turn decreased pyruvate kinase PKM2 activity while increasing phosphoglycerate dehydrogenase levels, and thereby promoted serine synthesis. We further showed that increased dSA induces the adaptive cellular and metabolic functions in the response of cells to decreased availability of serine likely by increasing Sph levels. Thus, we conclude that dSA functions as an initial sensor of serine loss, SK1 functions as its direct target, and Sph functions as a downstream effector of cellular and metabolic adaptations. These studies define a previously unrecognized "physiological" nontoxic function for dSA., Competing Interests: Conflict of interest The authors report no conflicts of interest., (Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
13. GRASP55 regulates intra-Golgi localization of glycosylation enzymes to control glycosphingolipid biosynthesis.
- Author
-
Pothukuchi P, Agliarulo I, Pirozzi M, Rizzo R, Russo D, Turacchio G, Nüchel J, Yang JS, Gehin C, Capolupo L, Hernandez-Corbacho MJ, Biswas A, Vanacore G, Dathan N, Nitta T, Henklein P, Thattai M, Inokuchi JI, Hsu VW, Plomann M, Obeid LM, Hannun YA, Luini A, D'Angelo G, and Parashuraman S
- Subjects
- Adaptor Proteins, Signal Transducing genetics, Adaptor Proteins, Signal Transducing metabolism, Autoantigens genetics, Autoantigens metabolism, Brefeldin A pharmacology, Ceramides metabolism, Cholera Toxin pharmacology, Cytoskeletal Proteins genetics, Cytoskeletal Proteins metabolism, Gene Expression, Glycosylation drug effects, Golgi Apparatus drug effects, Golgi Apparatus genetics, Golgi Matrix Proteins genetics, HeLa Cells, Humans, Membrane Proteins genetics, Membrane Proteins metabolism, Protein Serine-Threonine Kinases genetics, Protein Serine-Threonine Kinases metabolism, Shiga Toxin pharmacology, Glycosphingolipids metabolism, Golgi Apparatus metabolism, Golgi Matrix Proteins metabolism
- Abstract
The Golgi apparatus, the main glycosylation station of the cell, consists of a stack of discontinuous cisternae. Glycosylation enzymes are usually concentrated in one or two specific cisternae along the cis-trans axis of the organelle. How such compartmentalized localization of enzymes is achieved and how it contributes to glycosylation are not clear. Here, we show that the Golgi matrix protein GRASP55 directs the compartmentalized localization of key enzymes involved in glycosphingolipid (GSL) biosynthesis. GRASP55 binds to these enzymes and prevents their entry into COPI-based retrograde transport vesicles, thus concentrating them in the trans-Golgi. In genome-edited cells lacking GRASP55, or in cells expressing mutant enzymes without GRASP55 binding sites, these enzymes relocate to the cis-Golgi, which affects glycosphingolipid biosynthesis by changing flux across metabolic branch points. These findings reveal a mechanism by which a matrix protein regulates polarized localization of glycosylation enzymes in the Golgi and controls competition in glycan biosynthesis., (© 2021 The Authors. Published under the terms of the CC BY NC ND 4.0 license.)
- Published
- 2021
- Full Text
- View/download PDF
14. A Milk-Fat Based Diet Increases Metastasis in the MMTV-PyMT Mouse Model of Breast Cancer.
- Author
-
Velazquez FN, Viscardi V, Montemage J, Zhang L, Trocchia C, Delamont MM, Ahmad R, Hannun YA, Obeid LM, and Snider AJ
- Subjects
- Animal Feed, Animals, Antigens, Polyomavirus Transforming, Breast Neoplasms genetics, Breast Neoplasms metabolism, Female, Lung Neoplasms genetics, Lung Neoplasms metabolism, Mammary Tumor Virus, Mouse genetics, Olive Oil toxicity, Risk Assessment, Risk Factors, Tumor Burden, Tumor Necrosis Factor-alpha metabolism, Breast Neoplasms pathology, Diet, High-Fat adverse effects, Dietary Fats toxicity, Fatty Acids toxicity, Lung Neoplasms secondary, Milk toxicity
- Abstract
A high-fat diet (HFD) and obesity are risk factors for many diseases including breast cancer. This is particularly important with close to 40% of the current adult population being overweight or obese. Previous studies have implicated that Mediterranean diets (MDs) partially protect against breast cancer. However, to date, the links between diet and breast cancer progression are not well defined. Therefore, to begin to define and assess this, we used an isocaloric control diet (CD) and two HFDs enriched with either olive oil (OOBD, high in oleate, and unsaturated fatty acid in MDs) or a milk fat-based diet (MFBD, high in palmitate and myristate, saturated fatty acids in Western diets) in a mammary polyomavirus middle T antigen mouse model (MMTV-PyMT) of breast cancer. Our data demonstrate that neither MFBD or OOBD altered the growth of primary tumors in the MMTV-PyMT mice. The examination of lung metastases revealed that OOBD mice exhibited fewer surface nodules and smaller metastases when compared to MFBD and CD mice. These data suggest that different fatty acids found in different sources of HFDs may alter breast cancer metastasis.
- Published
- 2021
- Full Text
- View/download PDF
15. Loss of sphingosine kinase 1 increases lung metastases in the MMTV-PyMT mouse model of breast cancer.
- Author
-
Velazquez FN, Zhang L, Viscardi V, Trocchia C, Hannun YA, Obeid LM, and Snider AJ
- Subjects
- Animals, Carcinogenesis, Disease Models, Animal, Female, Gene Expression Regulation, Neoplastic, Mice, Mice, Knockout, Lung Neoplasms secondary, Mammary Neoplasms, Experimental metabolism, Phosphotransferases (Alcohol Group Acceptor) physiology, Retroviridae Infections metabolism, Tumor Virus Infections metabolism
- Abstract
Breast cancer is a very heterogeneous disease, and ~30% of breast cancer patients succumb to metastasis, highlighting the need to understand the mechanisms of breast cancer progression in order to identify new molecular targets for treatment. Sphingosine kinase 1 (SK1) has been shown to be upregulated in patients with breast cancer, and several studies have suggested its involvement in breast cancer progression and/or metastasis, mostly based on cell studies. In this work we evaluated the role of SK1 in breast cancer development and metastasis using a transgenic breast cancer model, mouse mammary tumor virus-polyoma middle tumor-antigen (MMTV-PyMT), that closely resembles the characteristics and evolution of human breast cancer. The results show that SK1 deficiency does not alter tumor latency or growth, but significantly increases the number of metastatic lung nodules and the average metastasis size in the lung of MMTV-PyMT mice. Additionally, analysis of Kaplan-Meier plotter of human disease shows that high SK1 mRNA expression can be associated with a better prognosis for breast cancer patients. These results suggest a metastasis-suppressing function for SK1 in the MMTV-PyMT model of breast cancer, and that its role in regulating human breast cancer progression and metastasis may be dependent on the breast cancer type., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2021
- Full Text
- View/download PDF
16. Ceramide kinase regulates TNF-α-induced immune responses in human monocytic cells.
- Author
-
Al-Rashed F, Ahmad Z, Snider AJ, Thomas R, Kochumon S, Melhem M, Sindhu S, Obeid LM, Al-Mulla F, Hannun YA, and Ahmad R
- Subjects
- Ceramides metabolism, Humans, Inflammation therapy, Molecular Targeted Therapy, Monocytes enzymology, Phosphorylation drug effects, Phosphotransferases (Alcohol Group Acceptor) metabolism, THP-1 Cells, Inflammation immunology, Monocytes immunology, Phosphotransferases (Alcohol Group Acceptor) physiology, Tumor Necrosis Factor-alpha adverse effects
- Abstract
Ceramide kinase (CERK) phosphorylates ceramide to produce ceramide-1-phosphate (C1P), which is involved in the development of metabolic inflammation. TNF-α modulates inflammatory responses in monocytes associated with various inflammatory disorders; however, the underlying mechanisms remain not fully understood. Here, we investigated the role of CERK in TNF-α-induced inflammatory responses in monocytes. Our results show that disruption of CERK activity in monocytes, either by chemical inhibitor NVP-231 or by small interfering RNA (siRNA), results in the defective expression of inflammatory markers including CD11c, CD11b and HLA-DR in response to TNF-α. Our data show that TNF-α upregulates ceramide phosphorylation. Inhibition of CERK in monocytes significantly reduced the secretion of IL-1β and MCP-1. Similar results were observed in CERK-downregulated cells. TNF-α-induced phosphorylation of JNK, p38 and NF-κB was reduced by inhibition of CERK. Additionally, NF-κB/AP-1 activity was suppressed by the inhibition of CERK. Clinically, obese individuals had higher levels of CERK expression in PBMCs compared to lean individuals, which correlated with their TNF-α levels. Taken together, these results suggest that CERK plays a key role in regulating inflammatory responses in human monocytes during TNF-α stimulation. CERK may be a relevant target for developing novel therapies for chronic inflammatory diseases.
- Published
- 2021
- Full Text
- View/download PDF
17. The doxorubicin-induced cell motility network is under the control of the ceramide-activated protein phosphatase 1 alpha.
- Author
-
Canals D, Salamone S, Santacreu BJ, Aguilar D, Hernandez-Corbacho MJ, Ostermeyer-Fay AG, Greene M, Nemeth E, Haley JD, Obeid LM, and Hannun YA
- Subjects
- Cell Adhesion drug effects, Cell Movement drug effects, HeLa Cells, Humans, Ceramides physiology, Doxorubicin pharmacology, Protein Phosphatase 1 physiology
- Abstract
We have recently reported that a specific pool of ceramide, located in the plasma membrane, mediated the effects of sublethal doses of the chemotherapeutic compound doxorubicin on enhancing cancer cell migration. We identified neutral sphingomyelinase 2 (nSMase2) as the enzyme responsible to generate this bioactive pool of ceramide. In this work, we explored the role of members of the protein phosphatases 1 family (PP1), and we identified protein phosphatase 1 alpha isoform (PP1 alpha) as the specific PP1 isoform to mediate this phenotype. Using a bioinformatics approach, we build a functional interaction network based on phosphoproteomics data on plasma membrane ceramide. This led to the identification of several ceramide-PP1 alpha downstream substrates. Studies on phospho mutants of ezrin (T567) and Scrib (S1378/S1508) demonstrated that their dephosphorylation is sufficient to enhance cell migration. In summary, we identified a mechanism where reduced doses of doxorubicin result in the dysregulation of cytoskeletal proteins and enhanced cell migration. This mechanism could explain the reported effects of doxorubicin worsening cancer metastasis in animal models., (© 2021 Federation of American Societies for Experimental Biology.)
- Published
- 2021
- Full Text
- View/download PDF
18. Sphingosine kinase 1 downregulation is required for adaptation to serine deprivation.
- Author
-
Truman JP, Ruiz CF, Trayssac M, Mao C, Hannun YA, and Obeid LM
- Subjects
- Down-Regulation, HCT116 Cells, Humans, Mitochondria metabolism, Oxygen metabolism, Phosphotransferases (Alcohol Group Acceptor) genetics, Proteasome Endopeptidase Complex metabolism, Reactive Oxygen Species metabolism, Serine metabolism, Tumor Suppressor Protein p53 metabolism, Adaptation, Physiological, Phosphotransferases (Alcohol Group Acceptor) metabolism, Proteolysis, Serine deficiency
- Abstract
It has been well-established that cancer cells often display altered metabolic profiles, and recent work has concentrated on how cancer cells adapt to serine removal. Serine can be either taken exogenously or synthesized from glucose, and its regulation forms an important mechanism for nutrient integration. One of the several important metabolic roles for serine is in the generation of bioactive sphingolipids since it is the main substrate for serine palmitoyltransferase, the initial and rate-limiting enzyme in the synthesis of sphingolipids. Previously, serine deprivation has been connected to the action of the tumor suppressor p53, and we have previously published on a role for p53 regulating sphingosine kinase 1 (SK1), an enzyme that phosphorylates sphingosine to form sphingosine-1-phosphate (S1P). SK1 is a key enzyme in sphingolipid synthesis that functions in pro-survival and tumor-promoting pathways and whose expression is also often elevated in cancers. Here we show that SK1 was degraded during serine starvation in a time and dose-dependent manner, which led to sphingosine accumulation. This was independent of effects on p53 but required the action of the proteasome. Furthermore, we show that overexpression of SK1, to compensate for SK1 loss, was detrimental to cell growth under conditions of serine starvation, demonstrating that the suppression of SK1 under these conditions is adaptive. Mitochondrial oxygen consumption decreased in response to SK1 degradation, and this was accompanied by an increase in intracellular reactive oxygen species (ROS). Suppression of ROS with N-acteylcysteine resulted in suppression of the metabolic adaptations and in decreased cell growth under serine deprivation. The effects of SK1 suppression on ROS were mimicked by D-erythro-sphingosine, whereas S1P was ineffective, suggesting that the effects of loss of SK1 were due to the accumulation of its substrate sphingosine. This study reveals a new mechanism for regulating SK1 levels and a link of SK1 to serine starvation as well as mitochondrial function., (© 2021 Federation of American Societies for Experimental Biology.)
- Published
- 2021
- Full Text
- View/download PDF
19. Targeting sphingosine kinase 1 (SK1) enhances oncogene-induced senescence through ceramide synthase 2 (CerS2)-mediated generation of very-long-chain ceramides.
- Author
-
Trayssac M, Clarke CJ, Stith JL, Snider JM, Newen N, Gault CR, Hannun YA, and Obeid LM
- Subjects
- Cell Line, Humans, Cellular Senescence, Ceramides metabolism, Genes, ras, Membrane Proteins metabolism, Phosphotransferases (Alcohol Group Acceptor) physiology, Sphingosine N-Acyltransferase metabolism, Tumor Suppressor Proteins metabolism
- Abstract
Senescence is an antiproliferative mechanism that can suppress tumor development and can be induced by oncogenes such as genes of the Ras family. Although studies have implicated bioactive sphingolipids (SL) in senescence, the specific mechanisms remain unclear. Here, using MCF10A mammary epithelial cells, we demonstrate that oncogenic K-Ras (Kirsten rat sarcoma viral oncogene homolog) is sufficient to induce cell transformation as well as cell senescence-as revealed by increases in the percentage of cells in the G1 phase of the cell cycle, p21
WAF1/Cip1/CDKN1A (p21) expression, and senescence-associated β-galactosidase activity (SA-β-gal). Furthermore, oncogenic K-Ras altered SL metabolism, with an increase of long-chain (LC) C18, C20 ceramides (Cer), and very-long-chain (VLC) C22:1, C24 Cer, and an increase of sphingosine kinase 1 (SK1) expression. Since Cer and sphingosine-1-phosphate have been shown to exert opposite effects on cellular senescence, we hypothesized that targeting SK1 could enhance oncogenic K-Ras-induced senescence. Indeed, SK1 downregulation or inhibition enhanced p21 expression and SA-β-gal in cells expressing oncogenic K-Ras and impeded cell growth. Moreover, SK1 knockdown further increased LC and VLC Cer species (C18, C20, C22:1, C24, C24:1, C26:1), especially the ones increased by oncogenic K-Ras. Fumonisin B1 (FB1), an inhibitor of ceramide synthases (CerS), reduced p21 expression induced by oncogenic K-Ras both with and without SK1 knockdown. Functionally, FB1 reversed the growth defect induced by oncogenic K-Ras, confirming the importance of Cer generation in the senescent phenotype. More specifically, downregulation of CerS2 by siRNA blocked the increase of VLC Cer (C24, C24:1, and C26:1) induced by SK1 knockdown and phenocopied the effects of FB1 on p21 expression. Taken together, these data show that targeting SK1 is a potential therapeutic strategy in cancer, enhancing oncogene-induced senescence through an increase of VLC Cer downstream of CerS2.- Published
- 2021
- Full Text
- View/download PDF
20. Erratum: Multiple actions of doxorubicin on the sphingolipid network revealed by flux analysis.
- Author
-
Snider JM, Trayssac M, Clarke CJ, Schwartz N, Snider AJ, Obeid LM, Luberto C, and Hannun YA
- Published
- 2021
- Full Text
- View/download PDF
21. Transcriptional Regulation of Sphingosine Kinase 1.
- Author
-
Bonica J, Mao C, Obeid LM, and Hannun YA
- Subjects
- Cytokines metabolism, Gene Expression Regulation, Enzymologic, Humans, Hypoxia pathology, MicroRNAs genetics, MicroRNAs metabolism, Phosphotransferases (Alcohol Group Acceptor) metabolism, RNA, Long Noncoding genetics, RNA, Long Noncoding metabolism, Phosphotransferases (Alcohol Group Acceptor) genetics
- Abstract
Once thought to be primarily structural in nature, sphingolipids have become increasingly appreciated as second messengers in a wide array of signaling pathways. Sphingosine kinase 1, or SK1, is one of two sphingosine kinases that phosphorylate sphingosine into sphingosine-1-phosphate (S1P). S1P is generally pro-inflammatory, pro-angiogenic, immunomodulatory, and pro-survival; therefore, high SK1 expression and activity have been associated with certain inflammatory diseases and cancer. It is thus important to develop an understanding of the regulation of SK1 expression and activity. In this review, we explore the current literature on SK1 transcriptional regulation, illustrating a complex system of transcription factors, cytokines, and even micro-RNAs (miRNAs) on the post transcriptional level.
- Published
- 2020
- Full Text
- View/download PDF
22. Maternal and fetal alkaline ceramidase 2 is required for placental vascular integrity in mice.
- Author
-
Li F, Xu R, Lin CL, Low BE, Cai L, Li S, Ji P, Huang L, Wiles MV, Hannun YA, Obeid LM, Chen Y, and Mao C
- Subjects
- Animals, Female, Hemorrhage etiology, Hemorrhage metabolism, Mice, Mice, Inbred C57BL, Mice, Knockout, Placenta metabolism, Pregnancy, Sphingosine metabolism, Vascular Diseases etiology, Vascular Diseases metabolism, Alkaline Ceramidase physiology, Hemorrhage pathology, Lysophospholipids metabolism, Placenta pathology, Sphingolipids metabolism, Sphingosine analogs & derivatives, Vascular Diseases pathology
- Abstract
Sphingolipids have been implicated in mammalian placental development and function, but their regulation in the placenta remains unclear. Herein we report that alkaline ceramidase 2 (ACER2) plays a key role in sustaining the integrity of the placental vasculature by regulating the homeostasis of sphingolipids in mice. The mouse alkaline ceramidase 2 gene (Acer2) is highly expressed in the placenta between embryonic day (E) 9.5 and E12.5. Acer2 deficiency in both the mother and fetus decreases the placental levels of sphingolipids, including sphingoid bases (sphingosine and dihydrosphingosine) and sphingoid base-1-phosphates (sphingosine-1-phosphate and dihydrosphingosine-1-phosphate) and results in the in utero death of ≈50% of embryos at E12.5 whereas Acer2 deficiency in either the mother or fetus has no such effects. Acer2 deficiency causes hemorrhages from the maternal vasculature in the junctional and/or labyrinthine zones in E12.5 placentas. Moreover, hemorrhagic but not non-hemorrhagic Acer2-deficient placentas exhibit an expansion of parietal trophoblast giant cells with a concomitant decrease in the area of the fetal blood vessel network in the labyrinthine zone, suggesting that Acer2 deficiency results in embryonic lethality due to the atrophy of the fetal blood vessel network in the placenta. Taken together, these results suggest that ACER2 sustains the integrity of the placental vasculature by controlling the homeostasis of sphingolipids in mice., (© 2020 Federation of American Societies for Experimental Biology.)
- Published
- 2020
- Full Text
- View/download PDF
23. Neutral sphingomyelinase 2 regulates inflammatory responses in monocytes/macrophages induced by TNF-α.
- Author
-
Al-Rashed F, Ahmad Z, Thomas R, Melhem M, Snider AJ, Obeid LM, Al-Mulla F, Hannun YA, and Ahmad R
- Subjects
- Adult, Blotting, Western, Flow Cytometry, Humans, Inflammation, Macrophages enzymology, Macrophages pathology, Middle Aged, Monocytes enzymology, Monocytes pathology, Real-Time Polymerase Chain Reaction, Macrophages drug effects, Monocytes drug effects, Sphingomyelin Phosphodiesterase metabolism, Tumor Necrosis Factor-alpha pharmacology
- Abstract
Obesity is associated with elevated levels of TNF-α and proinflammatory CD11c monocytes/macrophages. TNF-α mediated dysregulation in the plasticity of monocytes/macrophages is concomitant with pathogenesis of several inflammatory diseases, including metabolic syndrome, but the underlying mechanisms are incompletely understood. Since neutral sphingomyelinase-2 (nSMase2: SMPD3) is a key enzyme for ceramide production involved in inflammation, we investigated whether nSMase2 contributed to the inflammatory changes in the monocytes/macrophages induced by TNF-α. In this study, we demonstrate that the disruption of nSMase activity in monocytes/macrophages either by chemical inhibitor GW4869 or small interfering RNA (siRNA) against SMPD3 results in defects in the TNF-α mediated expression of CD11c. Furthermore, blockage of nSMase in monocytes/macrophages inhibited the secretion of inflammatory mediators IL-1β and MCP-1. In contrast, inhibition of acid SMase (aSMase) activity did not attenuate CD11c expression or secretion of IL-1β and MCP-1. TNF-α-induced phosphorylation of JNK, p38 and NF-κB was also attenuated by the inhibition of nSMase2. Moreover, NF-kB/AP-1 activity was blocked by the inhibition of nSMase2. SMPD3 was elevated in PBMCs from obese individuals and positively corelated with TNF-α gene expression. These findings indicate that nSMase2 acts, at least in part, as a master switch in the TNF-α mediated inflammatory responses in monocytes/macrophages.
- Published
- 2020
- Full Text
- View/download PDF
24. Ceramide launches an acute anti-adhesion pro-migration cell signaling program in response to chemotherapy.
- Author
-
Canals D, Salamone S, Santacreu BJ, Nemeth E, Aguilar D, Hernandez-Corbacho MJ, Adada M, Staquicini DI, Arap W, Pasqualini R, Haley J, Obeid LM, and Hannun YA
- Subjects
- Cell Line, Tumor, Cell Membrane drug effects, Cell Membrane metabolism, HeLa Cells, Humans, Phosphorylation drug effects, Sphingomyelin Phosphodiesterase metabolism, Antineoplastic Agents pharmacology, Cell Adhesion drug effects, Cell Movement drug effects, Ceramides pharmacology, Signal Transduction drug effects
- Abstract
Chemotherapy has been reported to upregulate sphingomylinases and increase cellular ceramide, often linked to the induction to cell death. In this work, we show that sublethal doses of doxorubicin and vorinostat still increased cellular ceramide, which was located predominantly at the plasma membrane. To interrogate possible functions of this specific pool of ceramide, we used recombinant enzymes to mimic physiological levels of ceramide at the plasma membrane upon chemotherapy treatment. Using mass spectrometry and network analysis, followed by experimental confirmation, the results revealed that this pool of ceramide acutely regulates cell adhesion and cell migration pathways with weak connections to commonly established ceramide functions (eg, cell death). Neutral sphingomyelinase 2 (nSMase2) was identified as responsible for the generation of plasma membrane ceramide upon chemotherapy treatment, and both ceramide at the plasma membrane and nSMase2 were necessary and sufficient to mediate these "side" effects of chemotherapy on cell adhesion and migration. This is the first time a specific pool of ceramide is interrogated for acute signaling functions, and the results define plasma membrane ceramide as an acute signaling effector necessary and sufficient for regulation of cell adhesion and cell migration under chemotherapeutical stress., (© 2020 Federation of American Societies for Experimental Biology.)
- Published
- 2020
- Full Text
- View/download PDF
25. Yeast Sphingolipid Phospholipase Gene ISC1 Regulates the Spindle Checkpoint by a CDC55 -Dependent Mechanism.
- Author
-
Matmati N, Hassan BH, Ren J, Shamssedine AA, Jeong E, Shariff B, Snider J, Rødkær SV, Chen G, Mohanty BK, Zheng WJ, Obeid LM, Røssel-Larsen M, Færgeman NJ, and Hannun YA
- Subjects
- Cell Cycle, Cell Cycle Proteins metabolism, Chromosome Segregation, Chromosomes, Fungal genetics, Chromosomes, Fungal metabolism, Gene Deletion, Gene Regulatory Networks, Genes, Fungal, Protein Phosphatase 2 metabolism, Saccharomyces cerevisiae cytology, Saccharomyces cerevisiae metabolism, Saccharomyces cerevisiae Proteins metabolism, Spindle Apparatus genetics, Spindle Apparatus metabolism, Type C Phospholipases metabolism, Cell Cycle Proteins genetics, Gene Expression Regulation, Fungal, Protein Phosphatase 2 genetics, Saccharomyces cerevisiae genetics, Saccharomyces cerevisiae Proteins genetics, Type C Phospholipases genetics
- Abstract
Defects in the spindle assembly checkpoint (SAC) can lead to aneuploidy and cancer. Sphingolipids have important roles in many cellular functions, including cell cycle regulation and apoptosis. However, the specific mechanisms and functions of sphingolipids in cell cycle regulation have not been elucidated. Using analysis of concordance for synthetic lethality for the yeast sphingolipid phospholipase ISC1 , we identified two groups of genes. The first comprises genes involved in chromosome segregation and stability ( CSM3 , CTF4 , YKE2 , DCC1 , and GIM4 ) as synthetically lethal with ISC1 The second group, to which ISC1 belongs, comprises genes involved in the spindle checkpoint ( BUB1 , MAD1 , BIM1 , and KAR3 ), and they all share the same synthetic lethality with the first group. We demonstrate that spindle checkpoint genes act upstream of Isc1, and their deletion phenocopies that of ISC1 Reciprocally, ISC1 deletion mutants were sensitive to benomyl, indicating a SAC defect. Similar to BUB1 deletion, ISC1 deletion prevents spindle elongation in hydroxyurea-treated cells. Mechanistically, PP2A-Cdc55 ceramide-activated phosphatase was found to act downstream of Isc1, thus coupling the spindle checkpoint genes and Isc1 to CDC55 -mediated nuclear functions., (Copyright © 2020 American Society for Microbiology.)
- Published
- 2020
- Full Text
- View/download PDF
26. Delivery of long chain C 16 and C 24 ceramide in HeLa cells using oxidized graphene nanoribbons.
- Author
-
Suhrland C, Truman JP, Obeid LM, and Sitharaman B
- Subjects
- Apoptosis, Cell Survival, HeLa Cells, Humans, Lipid Metabolism, Mass Spectrometry, Microscopy, Confocal, Microscopy, Electron, Transmission, Oxygen chemistry, Particle Size, Signal Transduction drug effects, Ultraviolet Rays, Carbon chemistry, Ceramides chemistry, Graphite chemistry, Metal Nanoparticles chemistry, Nanotubes, Carbon chemistry
- Abstract
The bioactive sphingolipid ceramide has many important roles in cell signaling processes, particularly in signaling programmed cell death in cancer. However, ceramide levels are often impaired in multi-drug resistant and radiation resistant cancers due to the dysregulation of ceramide metabolism. Restoration of ceramide levels through external delivery therefore represents a potential therapeutic target for the treatment of resistant cancers. However, as a lipid, ceramide is extremely hydrophobic and requires a delivery system to enter cells. Here we report the development of a method to load significant amounts of the long chain C
16 and C24 ceramides onto oxidized graphene nanoribbons (O-GNRs) derived from carbon nanotubes. Using O-GNRs as a delivery system for these ceramides, we were able to induce significant biological effects in HeLa cells in conjunction with C6 ceramide and ultraviolet radiation treatment. However, we found that O-GNRs themselves exert significant biological effects and can interfere with the actions of these ceramides and ultraviolet treatment. Loading of ceramides onto O-GNRs did not have a significant effect on the entry of the nanoparticles into cells. Despite the need for further improvement, these data represent an important first step in the development of O-GNRs as a delivery system for long chain ceramides., (© 2019 Wiley Periodicals, Inc.)- Published
- 2020
- Full Text
- View/download PDF
27. Correction: PKCα is required for Akt-mTORC1 activation in non-small cell lung carcinoma (NSCLC) with EGFR mutation.
- Author
-
Salama MF, Liu M, Clarke CJ, Espaillat MP, Haley JD, Jin T, Wang D, Obeid LM, and Hannun YA
- Abstract
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
- Published
- 2019
- Full Text
- View/download PDF
28. Probing compartment-specific sphingolipids with targeted bacterial sphingomyelinases and ceramidases.
- Author
-
Sakamoto W, Canals D, Salamone S, Allopenna J, Clarke CJ, Snider J, Obeid LM, and Hannun YA
- Subjects
- Cell Line, Ceramides metabolism, Endoplasmic Reticulum metabolism, Golgi Apparatus metabolism, Humans, Ceramidases metabolism, Sphingolipids metabolism, Sphingomyelin Phosphodiesterase metabolism
- Abstract
Sphingolipids contribute to the regulation of cell and tissue homeostasis, and disorders of sphingolipid metabolism lead to diseases such as inflammation, stroke, diabetes, and cancer. Sphingolipid metabolic pathways involve an array of enzymes that reside in specific subcellular organelles, resulting in the formation of many diverse sphingolipids with distinct molecular species based on the diversity of the ceramide (Cer) structure. In order to probe compartment-specific metabolism of sphingolipids in this study, we analyzed the Cer and SM species preferentially produced in the inner plasma membrane (PM), Golgi apparatus, ER, mitochondria, nucleus, and cytoplasm by using compartmentally targeted bacterial SMases and ceramidases. The results showed that the length of the acyl chain of Cer becomes longer according to the progress of Cer from synthesis in the ER to the Golgi apparatus, then to the PM. These findings suggest that each organelle shows different properties of SM-derived Cers consistent with its emerging distinct functions in vitro and in vivo.
- Published
- 2019
- Full Text
- View/download PDF
29. PKCα is required for Akt-mTORC1 activation in non-small cell lung carcinoma (NSCLC) with EGFR mutation.
- Author
-
Salama MF, Liu M, Clarke CJ, Espaillat MP, Haley JD, Jin T, Wang D, Obeid LM, and Hannun YA
- Subjects
- Apoptosis, Biomarkers, Tumor genetics, Carcinoma, Non-Small-Cell Lung genetics, Carcinoma, Non-Small-Cell Lung metabolism, Cell Proliferation, ErbB Receptors genetics, Humans, Lung Neoplasms genetics, Lung Neoplasms metabolism, Lung Neoplasms pathology, Mechanistic Target of Rapamycin Complex 1 genetics, Protein Kinase C-alpha genetics, Proto-Oncogene Proteins c-akt genetics, TOR Serine-Threonine Kinases genetics, TOR Serine-Threonine Kinases metabolism, Tumor Cells, Cultured, Carcinoma, Non-Small-Cell Lung pathology, Gene Expression Regulation, Neoplastic, Mechanistic Target of Rapamycin Complex 1 metabolism, Mutation, Protein Kinase C-alpha metabolism, Proto-Oncogene Proteins c-akt metabolism
- Abstract
Mutational activation of the epidermal growth factor receptor (EGFR) is a major player in the pathogenesis of non-small cell lung cancer (NSCLC). NSCLC patients with constitutively active EGFR mutations eventually develop drug resistance against EGFR tyrosine-kinase inhibitors; therefore, better understandings of key components of mutant EGFR (mtEGFR) signaling are required. Here, we initially observed aberrantly high expression of protein kinase Cα (PKCα) in lung adenocarcinomas, especially those with EGFR mutations, and proceeded to examine the role of PKCα in the regulation of the signaling pathways downstream of mtEGFR. The results showed that NSCLC cell lines with constitutively active EGFR mutations tend to have very or moderately high PKCα levels. Furthermore, PKCα was constitutively activated in HCC827 and H4006 cells which have an EGFR deletion mutation in exon 19. Interestingly, mtEGFR was not required for the induction of PKCα at protein and message levels suggesting that the increased levels of PKCα are due to independent selection. On the other hand, mtEGFR activity was required for robust activation of PKCα. Loss of functions studies revealed that the NSCLC cells rely heavily on PKCα for the activation of the mTORC1 signaling pathway. Unexpectedly, the results demonstrated that PKCα was required for activation of Akt upstream of mTOR but only in cells with the mtEGFR and with the increased expression of PKCα. Functionally, inhibition of PKCα in HCC827 led to caspase-3-dependent apoptosis and a significant decrease in cell survival in response to cellular stress induced by serum starvation. In summary, the results identified important roles of PKCα in regulating mTORC1 activity in lung cancer cells, whereby a primary switching occurs from PKCα-independent to PKCα-dependent signaling in the presence of EGFR mutations. The results present PKCα as a potential synergistic target of personalized treatment for NSCLC with constitutively active mutant forms of EGFR and constitutively active PKCα.
- Published
- 2019
- Full Text
- View/download PDF
30. Advances in determining signaling mechanisms of ceramide and role in disease.
- Author
-
Stith JL, Velazquez FN, and Obeid LM
- Subjects
- Animals, Carrier Proteins chemistry, Carrier Proteins metabolism, Ceramides chemistry, Heart Diseases diagnosis, Heart Diseases metabolism, Humans, Inflammatory Bowel Diseases diagnosis, Inflammatory Bowel Diseases metabolism, Mice, Mice, Knockout, Multiple Sclerosis diagnosis, Multiple Sclerosis metabolism, Neoplasms diagnosis, Nervous System Diseases diagnosis, Nervous System Diseases metabolism, Obesity diagnosis, Obesity metabolism, Ceramides metabolism, Neoplasms metabolism, Signal Transduction
- Abstract
Ceramide is a critical bioactive lipid involved in diverse cellular processes. It has been proposed to regulate cellular processes by influencing membrane properties and by directly interacting with effector proteins. Advances over the past decade have improved our understanding of ceramide as a bioactive lipid. Generation and characterization of ceramide-metabolizing enzyme KO mice, development of specific inhibitors and ceramide-specific antibodies, use of advanced microscopy and mass spectrometry, and design of synthetic ceramide derivatives have all provided insight into the signaling mechanisms of ceramide and its implications in disease. As a result, the role of ceramide in biological functions and disease are now better understood, with promise for development of therapeutic strategies to treat ceramide-regulated diseases.
- Published
- 2019
- Full Text
- View/download PDF
31. A novel role for DGATs in cancer.
- Author
-
Hernández-Corbacho MJ and Obeid LM
- Subjects
- Animals, Ceramides metabolism, Diacylglycerol O-Acyltransferase antagonists & inhibitors, Diacylglycerol O-Acyltransferase genetics, Enzyme Inhibitors administration & dosage, Humans, Neoplasms drug therapy, Neoplasms genetics, Neoplasms metabolism, Diacylglycerol O-Acyltransferase metabolism, Neoplasms enzymology
- Published
- 2019
- Full Text
- View/download PDF
32. Quantifying 1-deoxydihydroceramides and 1-deoxyceramides in mouse nervous system tissue.
- Author
-
Schwartz NU, Mileva I, Gurevich M, Snider J, Hannun YA, and Obeid LM
- Subjects
- Aging metabolism, Animals, Mice, Mice, Inbred C57BL, Ceramides metabolism, Nervous System metabolism
- Abstract
Accumulation of deoxysphingolipids (deoxySLs) has been implicated in many neural diseases, although mechanisms remain unclear. A major obstacle limiting understanding of deoxySLs has been the lack of a method easily defining measurement of deoxydihydroceramide (deoxydhCer) and deoxyceramide (deoxyCer) in neural tissues. Furthermore, it is poorly understood if deoxySLs accumulate in the nervous system with aging. To facilitate investigation of deoxydhCer and deoxyCer in nervous system tissue, we developed a method to evaluate levels of these lipids in mouse brain, spinal cord, and sciatic nerve. Many deoxydhCers and brain C24-deoxyCer were present at 1, 3, and 6 months of age. Furthermore, while ceramide levels decreased with age, deoxydhCers increased in sciatic nerve and spinal cord, suggesting they may accumulate in peripheral nerves. C22-deoxydhCer was the highest deoxydhCer species in all tissues, suggesting it may be important physiologically. The development of this method will facilitate straightforward profiling of deoxydhCers and deoxyCers and the study of their metabolism and function. These results also reveal that deoxydhCers accumulate in peripheral nerves with normal aging., (Published by Elsevier Inc.)
- Published
- 2019
- Full Text
- View/download PDF
33. Multiple actions of doxorubicin on the sphingolipid network revealed by flux analysis.
- Author
-
Snider JM, Trayssac M, Clarke CJ, Schwartz N, Snider AJ, Obeid LM, Luberto C, and Hannun YA
- Subjects
- Biological Transport drug effects, Dose-Response Relationship, Drug, Humans, MCF-7 Cells, Sphingolipids metabolism, Structure-Activity Relationship, Tumor Cells, Cultured, Antibiotics, Antineoplastic pharmacology, Doxorubicin pharmacology, Metabolic Networks and Pathways, Sphingolipids antagonists & inhibitors
- Abstract
Sphingolipids (SLs) have been implicated in numerous important cellular biologies; however, their study has been hindered by the complexities of SL metabolism. Furthermore, enzymes of SL metabolism represent a dynamic and interconnected network in which one metabolite can be transformed into other bioactive SLs through further metabolism, resulting in diverse cellular responses. Here we explore the effects of both lethal and sublethal doses of doxorubicin (Dox) in MCF-7 cells. The two concentrations of Dox resulted in the regulation of SLs, including accumulations in sphingosine, sphingosine-1-phosphate, dihydroceramide, and ceramide, as well as reduced levels of hexosylceramide. To further define the effects of Dox on SLs, metabolic flux experiments utilizing a d17 dihydrosphingosine probe were conducted. Results indicated the regulation of ceramidases and sphingomyelin synthase components specifically in response to the cytostatic dose. The results also unexpectedly demonstrated dose-dependent inhibition of dihydroceramide desaturase and glucosylceramide synthase in response to Dox. Taken together, this study uncovers novel targets in the SL network for the action of Dox, and the results reveal the significant complexity of SL response to even a single agent. This approach helps to define the role of specific SL enzymes, their metabolic products, and the resulting biologies in response to chemotherapeutics and other stimuli.
- Published
- 2019
- Full Text
- View/download PDF
34. Oxidized graphene nanoparticles as a delivery system for the pro-apoptotic sphingolipid C 6 ceramide.
- Author
-
Suhrland C, Truman JP, Obeid LM, and Sitharaman B
- Subjects
- Cell Survival drug effects, HeLa Cells, Humans, Oxidation-Reduction, Ceramides chemistry, Ceramides pharmacokinetics, Ceramides pharmacology, Coated Materials, Biocompatible chemistry, Coated Materials, Biocompatible pharmacokinetics, Coated Materials, Biocompatible pharmacology, Drug Delivery Systems, Graphite chemistry, Graphite pharmacokinetics, Graphite pharmacology
- Abstract
Sphingolipids such as ceramide have attracted much attention as possible anticancer agents due to their potent pro-apoptotic effects. However, due to their extreme hydrophobicity, there is currently no clinically approved delivery method for in vivo use as a therapeutic agent. To this end, we have developed a novel method for loading the short-chain C
6 ceramide onto oxidized graphene nanoribbons (O-GNRs) and graphene nanoplatelets (GNPs). Mass spectrometry revealed loading efficiencies of 57% and 51.5% for C6 ceramide onto O-GNRs and GNPs, respectively. The PrestoBlue viability assay revealed that 100 µg/mL of C6 ceramide-loaded O-GNRs and C6 ceramide-loaded GNPs reduced HeLa cell viability by approximately 93% and approximately 76%, respectively, compared to untreated HeLa cells, while equal concentrations of these nanoparticles without C6 ceramide did not significantly reduce HeLa cell viability. We confirmed that this cytotoxicity was apoptotic in nature via capase-3 activity and Hoechst staining. Using live-cell confocal imaging with the fluorescent NBD-ceramide loaded on O-GNRs, we observed robust uptake into HeLa cells within 30 min while NBD-ceramide on its own was uptaken much more rapidly. Transmission electron microscopy confirmed that C6 ceramide-loaded O-GNRs were actually entering cells. Taken together, these data show that O-GNRs are a promising delivery agent for ceramide. To our knowledge, this study is the first to use such a loading method. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 107A: 25-37, 2019., (© 2018 Wiley Periodicals, Inc.)- Published
- 2019
- Full Text
- View/download PDF
35. Functions of neutral ceramidase in the Golgi apparatus.
- Author
-
Sakamoto W, Coant N, Canals D, Obeid LM, and Hannun YA
- Subjects
- Apoptosis physiology, Blotting, Western, Cell Membrane metabolism, Cell Survival physiology, Colonic Neoplasms metabolism, HCT116 Cells, Humans, Lipid Metabolism physiology, Microscopy, Confocal, Signal Transduction physiology, Sphingolipids metabolism, Sphingomyelin Phosphodiesterase metabolism, Golgi Apparatus metabolism, Neutral Ceramidase metabolism
- Abstract
Ceramidases hydrolyze ceramides into sphingosine and fatty acids, with sphingosine being further metabolized into sphingosine-1-phosphate (S1P); thus, ceramidases control the levels of these bioactive sphingolipids in cells and tissues. Neutral ceramidase (nCDase) is highly expressed in colorectal tissues, and a recent report showed that nCDase activity is involved in Wnt/β-catenin signaling. In addition, the inhibition of nCDase decreases the development and progression of colorectal tumor growth. Here, to determine the action of nCDase in colorectal cancer cells, we focused on the subcellular localization and metabolic functions of this enzyme in HCT116 cells. nCDase was found to be located in both the plasma membrane and in the Golgi apparatus, but it had minimal effects on basal levels of ceramide, sphingosine, or S1P. Cells overexpressing nCDase were protected from the cell death and Golgi fragmentation induced by C6-ceramide, and they showed reduced levels of C6-ceramide and higher levels of S1P and sphingosine. Furthermore, compartment-specific metabolic functions of the enzyme were probed using C6-ceramide and Golgi-targeted bacterial SMase (bSMase) and bacterial ceramidase (bCDase). The results showed that Golgi-specific bCDase also demonstrated resistance against the cell death stimulated by C6-ceramide, and it catalyzed the metabolism of ceramides and produced sphingosine in the Golgi. Targeting bSMase to the Golgi resulted in increased levels of ceramide that were attenuated by the expression of nCDase, also supporting its ability to metabolize Golgi-generated ceramide. These results are critical in understanding the functions of nCDase actions in colorectal cancer cells as well as the compartmentalized pathways of sphingolipid metabolism.
- Published
- 2018
- Full Text
- View/download PDF
36. Molecular mechanisms of regulation of sphingosine kinase 1.
- Author
-
Pulkoski-Gross MJ and Obeid LM
- Subjects
- Animals, Enzyme Activation, Enzyme Stability, Gene Expression Regulation, Humans, Models, Molecular, Phosphotransferases (Alcohol Group Acceptor) chemistry, Protein Biosynthesis, Signal Transduction, Sphingosine metabolism, Transcription, Genetic, Cell Membrane metabolism, Lysophospholipids metabolism, Phosphotransferases (Alcohol Group Acceptor) genetics, Phosphotransferases (Alcohol Group Acceptor) metabolism, Sphingosine analogs & derivatives
- Abstract
Within the last 3 decades, there has been intense study of bioactive sphingolipids and the enzymes which metabolize those lipids. One enzyme is the critical lipid kinase sphingosine kinase 1 (SK1), which produces the potent and pleiotropic signaling lipid, sphingosine 1-phosphate (S1P). SK1 and S1P have been implicated in a host of different diseases including cancer, chronic inflammation, and metabolic diseases. However, while there is ample knowledge about the importance of these molecules in the development and progression of disease there is a dearth of knowledge of the molecular mechanisms which regulate SK1 function. In this review, we will cover some of the more recent and exciting findings about the different ways SK1 function can be regulated, from transcriptional regulation to protein stability. Finally, we will delve into recent structural insights into SK1 and how they might relate to function at cell membranes., (Published by Elsevier B.V.)
- Published
- 2018
- Full Text
- View/download PDF
37. Tsc3 regulates SPT amino acid choice in Saccharomyces cerevisiae by promoting alanine in the sphingolipid pathway.
- Author
-
Ren J, Saied EM, Zhong A, Snider J, Ruiz C, Arenz C, Obeid LM, Girnun GD, and Hannun YA
- Subjects
- Mass Spectrometry, Mutation genetics, Plasmids genetics, Serine metabolism, Substrate Specificity, Alanine metabolism, Ceramides metabolism, Saccharomyces cerevisiae metabolism, Serine C-Palmitoyltransferase metabolism, Sphingolipids metabolism
- Abstract
The generation of most sphingolipids (SPLs) starts with condensation between serine and an activated long-chain fatty acid catalyzed by serine palmitoyltransferase (SPT). SPT can also use other amino acids to generate small quantities of noncanonical SPLs. The balance between serine-derived and noncanonical SPLs is pivotal; for example, hereditary sensory and autonomic neuropathy type I results from SPT mutations that cause an abnormal accumulation of alanine-derived SPLs. The regulatory mechanism for SPT amino acid selectivity and physiological functions of noncanonical SPLs are unknown. We investigated SPT selection of amino acid substrates by measuring condensation products of serine and alanine in yeast cultures and SPT use of serine and alanine in a TSC3 knockout model. We identified the Tsc3 subunit of SPT as a regulator of amino acid substrate selectivity by demonstrating its primary function in promoting alanine utilization by SPT and confirmed its requirement for the inhibitory effect of alanine on SPT utilization of serine. Moreover, we observed downstream metabolic consequences to Tsc3 loss: serine influx into the SPL biosynthesis pathway increased through Ypk1-depenedent activation of SPT and ceramide synthases. This Ypk1-dependent activation of serine influx after Tsc3 knockout suggests a potential function for deoxy-sphingoid bases in modulating Ypk1 signaling.
- Published
- 2018
- Full Text
- View/download PDF
38. Long-chain acyl-CoA synthetase 1 interacts with key proteins that activate and direct fatty acids into niche hepatic pathways.
- Author
-
Young PA, Senkal CE, Suchanek AL, Grevengoed TJ, Lin DD, Zhao L, Crunk AE, Klett EL, Füllekrug J, Obeid LM, and Coleman RA
- Subjects
- Animals, Female, Liver cytology, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Coenzyme A Ligases physiology, Endoplasmic Reticulum metabolism, Fatty Acids metabolism, Liver metabolism, Mitochondria metabolism, Protein Interaction Domains and Motifs
- Abstract
Fatty acid channeling into oxidation or storage modes depends on physiological conditions and hormonal signaling. However, the directionality of this channeling may also depend on the association of each of the five acyl-CoA synthetase isoforms with specific protein partners. Long-chain acyl-CoA synthetases (ACSLs) catalyze the conversion of long-chain fatty acids to fatty acyl-CoAs, which are then either oxidized or used in esterification reactions. In highly oxidative tissues, ACSL1 is located on the outer mitochondrial membrane (OMM) and directs fatty acids into mitochondria for β-oxidation. In the liver, however, about 50% of ACSL1 is located on the endoplasmic reticulum (ER) where its metabolic function is unclear. Because hepatic fatty acid partitioning is likely to require the interaction of ACSL1 with other specific proteins, we used an unbiased protein interaction technique, BioID, to discover ACSL1-binding partners in hepatocytes. We targeted ACSL1 either to the ER or to the OMM of Hepa 1-6 cells as a fusion protein with the Escherichia coli biotin ligase, BirA*. Proteomic analysis identified 98 proteins that specifically interacted with ACSL1 at the ER, 55 at the OMM, and 43 common to both subcellular locations. We found subsets of peroxisomal and lipid droplet proteins, tethering proteins, and vesicle proteins, uncovering a dynamic role for ACSL1 in organelle and lipid droplet interactions. Proteins involved in lipid metabolism were also identified, including acyl-CoA-binding proteins and ceramide synthase isoforms 2 and 5. Our results provide fundamental and detailed insights into protein interaction networks that control fatty acid metabolism., (© 2018 Young et al.)
- Published
- 2018
- Full Text
- View/download PDF
39. Author Correction: Sphingolipids and their metabolism in physiology and disease.
- Author
-
Hannun YA and Obeid LM
- Abstract
In the original Figure 2, sphingolipids on the endosomal and lysosomal membranes are facing the outside of these organelles. The correct orientation of these species should be towards the lumen, as shown in the corrected figure.
- Published
- 2018
- Full Text
- View/download PDF
40. Role of sphingolipids in senescence: implication in aging and age-related diseases.
- Author
-
Trayssac M, Hannun YA, and Obeid LM
- Subjects
- Aging pathology, Alzheimer Disease metabolism, Alzheimer Disease pathology, Animals, Atherosclerosis metabolism, Atherosclerosis pathology, Biomarkers metabolism, Cellular Senescence physiology, Ceramides metabolism, Diabetes Mellitus, Type 2 metabolism, Diabetes Mellitus, Type 2 pathology, Humans, Immune System metabolism, Immune System pathology, Lysophospholipids metabolism, Metabolic Networks and Pathways, Models, Biological, Neoplasms metabolism, Neoplasms pathology, Sphingosine analogs & derivatives, Sphingosine metabolism, Aging metabolism, Sphingolipids metabolism
- Abstract
Aging is defined as the progressive deterioration of physiological function with age. Incidence of many pathologies increases with age, including neurological and cardiovascular diseases and cancer. Aging tissues become less adaptable and renewable, and cells undergo senescence, a process by which they "irreversibly" stop dividing. Senescence has been shown to serve as a tumor suppression mechanism with clear desirable effects. However, senescence also has deleterious consequences, especially for cardiovascular, metabolic, and immune systems. Sphingolipids are a major class of lipids that regulate cell biology, owing to their structural and bioactive properties and diversity. Their involvement in the regulation of aging and senescence has been demonstrated and studied in multiple organisms and cell types, especially that of ceramide and sphingosine-1-phosphate; ceramide induces cellular senescence and sphingosine-1-phosphate delays it. These discoveries could be very useful in the future to understand aging mechanisms and improve therapeutic interventions.
- Published
- 2018
- Full Text
- View/download PDF
41. Identification of an acid sphingomyelinase ceramide kinase pathway in the regulation of the chemokine CCL5.
- Author
-
Newcomb B, Rhein C, Mileva I, Ahmad R, Clarke CJ, Snider J, Obeid LM, and Hannun YA
- Subjects
- Cell Movement drug effects, Ceramides metabolism, Chemokine CCL5 biosynthesis, Epithelial-Mesenchymal Transition drug effects, Humans, MCF-7 Cells, Signal Transduction drug effects, Tumor Necrosis Factor-alpha pharmacology, Chemokine CCL5 metabolism, Phosphotransferases (Alcohol Group Acceptor) metabolism, Sphingomyelin Phosphodiesterase metabolism
- Abstract
Acid sphingomyelinase (ASM) hydrolyzes sphingomyelin to produce the biologically active lipid ceramide. Previous studies have implicated ASM in the induction of the chemokine CCL5 in response to TNF-α however, the lipid mediator of this effect was not established. In the present study, we identified a novel pathway connecting ASM and ceramide kinase (CERK). The results show that TNF-α induces the formation of ceramide 1-phosphate (C-1-P) in a CERK-dependent manner. Silencing of CERK blocks CCL5 production in response to TNF-α. Interestingly, cells lacking ASM have decreased C-1-P production following TNF-α treatment, suggesting that ASM may be acting upstream of CERK. Functionally, ASM and CERK induce a highly concordant program of cytokine production and both are required for migration of breast cancer cells. Taken together, these data suggest ASM can produce ceramide which is then converted to C-1-P by CERK, and that C-1-P is required for production of CCL5 and several cytokines and chemokines, with roles in cell migration. These results highlight the diversity in action of ASM through more than one bioactive sphingolipid., (Copyright © 2018 Newcomb et al.)
- Published
- 2018
- Full Text
- View/download PDF
42. AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells.
- Author
-
Coant N, García-Barros M, Zhang Q, Obeid LM, and Hannun YA
- Subjects
- Animals, Apoptosis physiology, Cell Line, Tumor, Colonic Neoplasms pathology, Glycogen Synthase Kinase 3 beta metabolism, HCT116 Cells, HT29 Cells, Humans, Lysophospholipids metabolism, Male, Mice, Mice, Nude, Phosphotransferases (Alcohol Group Acceptor) metabolism, Sphingolipids metabolism, Sphingosine analogs & derivatives, Sphingosine metabolism, beta Catenin metabolism, Cell Proliferation physiology, Colonic Neoplasms metabolism, Neutral Ceramidase metabolism, Proto-Oncogene Proteins c-akt metabolism
- Abstract
Despite advances in the field, colorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide. Research into bioactive sphingolipids over the past two decades has played an important role in increasing our understanding of the pathogenesis and therapeutics of CRC. In the complex metabolic network of sphingolipids, ceramidases (CDases) have a key function. These enzymes hydrolyze ceramides into sphingosine (SPH) which in turn is phosphorylated by sphingosine kinases (SK) 1 and 2 to generate sphingosine-1 phosphate (S1P). Importantly, we have recently shown that inhibition of neutral CDase (nCDase) induces an increase of ceramide in colon cancer cells which decreases cellular growth, increases apoptosis and modulates the WNT/β-catenin pathway. We have also shown that the deletion of nCDase protected mice from the onset and progression of colorectal cancer in the AOM carcinogen model. Here, we demonstrate that AKT is a key target for the growth suppressing functions of ceramide. The results show that inhibition of nCDase activates GSK3β through dephosphorylation, and thus is required for the subsequent phosphorylation and degradation of β-catenin. Our findings show that inhibition of nCDase also inhibits the basal activation status of AKT, and we further establish that a constitutively active AKT (AKT T308D, S473D; AKT
DD ) reverses the effect of nCDase on β-catenin degradation. Functionally, the AKTDD mutant is able to overcome the growth suppressive effects of nCDase inhibition in CRC cells. Moreover, nCDase inhibition induces a growth delay of xenograft tumors from control cells, whereas xenograft tumors from constitutively active AKT cells become resistant to nCDase inhibition. Taken together, these results provide important mechanistic insight into how nCDase regulates cell proliferation. These findings demonstrate a heretofore unappreciated, but critical, role for nCDase in enabling/maintaining basal activation of AKT and also suggest that nCDase is a suitable novel target for colon cancer therapy.- Published
- 2018
- Full Text
- View/download PDF
43. Probing de novo sphingolipid metabolism in mammalian cells utilizing mass spectrometry.
- Author
-
Snider JM, Snider AJ, Obeid LM, Luberto C, and Hannun YA
- Subjects
- Chromatography, Liquid, Humans, MCF-7 Cells, Oxidoreductases metabolism, Phosphates metabolism, Time Factors, Mass Spectrometry methods, Sphingolipids metabolism
- Abstract
Sphingolipids constitute a dynamic metabolic network that interconnects several bioactive molecules, including ceramide (Cer), sphingosine (Sph), Sph 1-phosphate, and Cer 1-phosphate. The interconversion of these metabolites is controlled by a cohort of at least 40 enzymes, many of which respond to endogenous or exogenous stimuli. Typical probing of the sphingolipid pathway relies on sphingolipid mass levels or determination of the activity of individual enzymes. Either approach is unable to provide a complete analysis of flux through sphingolipid metabolism, which, given the interconnectivity of the sphingolipid pathway, is critical information to identify nodes of regulation. Here, we present a one-step in situ assay that comprehensively probes the flux through de novo sphingolipid synthesis, post serine palmitoyltransferase, by monitoring the incorporation and metabolism of the 17 carbon dihydrosphingosine precursor with LC/MS. Pulse labeling and analysis of precursor metabolism identified sequential well-defined phases of sphingolipid synthesis, corresponding to the activity of different enzymes in the pathway, further confirmed by the use of specific inhibitors and modulators of sphingolipid metabolism. This work establishes precursor pulse labeling as a practical tool for comprehensively studying metabolic flux through de novo sphingolipid synthesis and complex sphingolipid generation.
- Published
- 2018
- Full Text
- View/download PDF
44. Alkaline ceramidase 2 is essential for the homeostasis of plasma sphingoid bases and their phosphates.
- Author
-
Li F, Xu R, Low BE, Lin CL, Garcia-Barros M, Schrandt J, Mileva I, Snider A, Luo CK, Jiang XC, Li MS, Hannun YA, Obeid LM, Wiles MV, and Mao C
- Subjects
- Alkaline Ceramidase genetics, Animals, Hematopoietic Stem Cells cytology, Humans, Mice, Mice, Knockout, Alkaline Ceramidase metabolism, Hematopoietic Stem Cells metabolism, Hemostasis physiology, Lysophospholipids blood, Sphingolipids blood, Sphingosine analogs & derivatives, Sphingosine blood
- Abstract
Sphingosine-1-phosphate (S1P) plays important roles in cardiovascular development and immunity. S1P is abundant in plasma because erythrocytes-the major source of S1P-lack any S1P-degrading activity; however, much remains unclear about the source of the plasma S1P precursor, sphingosine (SPH), derived mainly from the hydrolysis of ceramides by the action of ceramidases that are encoded by 5 distinct genes, acid ceramidase 1 ( ASAH1)/ Asah1, ASAH2/ Asah2, alkaline ceramidase 1 ( ACER1)/ Acer1, ACER2/ Acer2, and ACER3/ Acer3, in humans/mice. Previous studies have reported that knocking out Asah1 or Asah2 failed to reduce plasma SPH and S1P levels in mice. In this study, we show that knocking out Acer1 or Acer3 also failed to reduce the blood levels of SPH or S1P in mice. In contrast, knocking out Acer2 from either whole-body or the hematopoietic lineage markedly decreased the blood levels of SPH and S1P in mice. Of interest, knocking out Acer2 from whole-body or the hematopoietic lineage also markedly decreased the levels of dihydrosphingosine (dhSPH) and dihydrosphingosine-1-phosphate (dhS1P) in blood. Taken together, these results suggest that ACER2 plays a key role in the maintenance of high plasma levels of sphingoid base-1-phosphates-S1P and dhS1P-by controlling the generation of sphingoid bases-SPH and dhSPH-in hematopoietic cells.-Li, F., Xu, R., Low, B. E., Lin, C.-L., Garcia-Barros, M., Schrandt, J., Mileva, I., Snider, A., Luo, C. K., Jiang, X.-C., Li, M.-S., Hannun, Y. A., Obeid, L. M., Wiles, M. V., Mao, C. Alkaline ceramidase 2 is essential for the homeostasis of plasma sphingoid bases and their phosphates.
- Published
- 2018
- Full Text
- View/download PDF
45. Tumor suppressor p53 links ceramide metabolism to DNA damage response through alkaline ceramidase 2.
- Author
-
Xu R, Garcia-Barros M, Wen S, Li F, Lin CL, Hannun YA, Obeid LM, and Mao C
- Subjects
- Alkaline Ceramidase genetics, Animals, Ceramides genetics, HeLa Cells, Humans, Lysophospholipids genetics, Mice, Nude, Sphingosine genetics, Sphingosine metabolism, Tumor Suppressor Protein p53 genetics, Alkaline Ceramidase metabolism, Apoptosis, Ceramides metabolism, DNA Damage, Lysophospholipids metabolism, Sphingosine analogs & derivatives, Tumor Suppressor Protein p53 metabolism
- Abstract
p53 mediates the DNA damage response (DDR) by regulating the expression of genes implicated in cell cycle arrest, senescence, programmed cell death (PCD), and metabolism. Herein we demonstrate that human alkaline ceramidase 2 (ACER2) is a novel transcriptional target of p53 and that its transactivation by p53 mediates the DDR. We found that p53 overexpression or its activation by ionizing radiation (IR) upregulated ACER2 in cells. Two putative p53 responsive elements (p53REs) were found in its first intron of the ACER2 gene, and Chromatin Immunoprecipitation (ChIP) assays in combination with promoter activity assays demonstrated that these p53REs are the bona fide p53 binding sites that mediate ACER2 transactivation by p53. As ACER2 catalyzes the hydrolysis of ceramides into sphingosine, which in turn is phosphorylated to form sphingosine-1-phosphate (S1P), ACER2 upregulation increased the levels of both sphingosine and S1P while decreasing the levels of ceramides in cells. A moderate upregulation of ACER2 inhibited cell cycle arrest and cellular senescence in response to low-level expression of p53 or low-dose IR by elevating S1P, a pro-proliferative and pro-survival bioactive lipid, and/or decreasing ceramides whereas its robust upregulation mediated PCD in response to high-level expression of p53 or high-dose IR likely by accumulating cellular sphingosine, a pro-death bioactive lipid. ACER2 is frequently inactivated in various cancers due to its deletion or mutations, and restoring its expression inhibited the growth of tumor xenografts in mice. These results suggest that p53 mediates DDR and exerts its tumor suppressive role in part by regulating the expression of ACER2, which in turn regulates the bioactive sphingolipid lipids.
- Published
- 2018
- Full Text
- View/download PDF
46. Loss of acid ceramidase in myeloid cells suppresses intestinal neutrophil recruitment.
- Author
-
Espaillat MP, Snider AJ, Qiu Z, Channer B, Coant N, Schuchman EH, Kew RR, Sheridan BS, Hannun YA, and Obeid LM
- Subjects
- Acid Ceramidase genetics, Animals, Chemokines biosynthesis, Chemokines genetics, Colitis, Ulcerative genetics, Colitis, Ulcerative pathology, Colon pathology, Colonic Neoplasms enzymology, Colonic Neoplasms genetics, Colonic Neoplasms pathology, Female, Humans, Intestinal Mucosa pathology, Male, Mice, Mice, Knockout, Myeloid-Derived Suppressor Cells enzymology, Myeloid-Derived Suppressor Cells pathology, Neoplasm Proteins genetics, Neoplasm Proteins metabolism, Neutrophils pathology, Tumor Microenvironment genetics, Acid Ceramidase biosynthesis, Colitis, Ulcerative enzymology, Colon enzymology, Gene Expression Regulation, Enzymologic, Intestinal Mucosa enzymology, Neutrophils enzymology, Up-Regulation
- Abstract
Bioactive sphingolipids are modulators of immune processes and their metabolism is often dysregulated in ulcerative colitis, a major category of inflammatory bowel disease (IBD). While multiple axes of sphingolipid metabolism have been investigated to delineate mechanisms regulating ulcerative colitis, the role of acid ceramidase (AC) in intestinal inflammation is yet to be characterized. Here we demonstrate that AC expression is elevated selectively in the inflammatory infiltrate in human and murine colitis. To probe for mechanistic insight into how AC up-regulation can impact intestinal inflammation, we investigated the selective loss of AC expression in the myeloid population. Using a model of intestinal epithelial injury, we demonstrate that myeloid AC conditional knockout mice exhibit impairment of neutrophil recruitment to the colon mucosa as a result of defective cytokine and chemokine production. Furthermore, the loss of myeloid AC protects from tumor incidence in colitis-associated cancer (CAC) and inhibits the expansion of neutrophils and granulocytic myeloid-derived suppressor cells in the tumor microenvironment. Collectively, our results demonstrate a tissue-specific role for AC in regulating neutrophilic inflammation and cytokine production. We demonstrate novel mechanisms of how granulocytes are recruited to the colon that may have therapeutic potential in intestinal inflammation, IBD, and CAC.-Espaillat, M. P., Snider, A. J., Qiu, Z., Channer, B., Coant, N., Schuchman, E. H., Kew, R. R., Sheridan, B. S., Hannun, Y. A., Obeid, L. M. Loss of acid ceramidase in myeloid cells suppresses intestinal neutrophil recruitment.
- Published
- 2018
- Full Text
- View/download PDF
47. An intrinsic lipid-binding interface controls sphingosine kinase 1 function.
- Author
-
Pulkoski-Gross MJ, Jenkins ML, Truman JP, Salama MF, Clarke CJ, Burke JE, Hannun YA, and Obeid LM
- Subjects
- Binding Sites, Cell Membrane metabolism, Deuterium Exchange Measurement, HCT116 Cells, Humans, Lysophospholipids biosynthesis, Mass Spectrometry, Phosphotransferases (Alcohol Group Acceptor) deficiency, Signal Transduction, Sphingosine biosynthesis, Sphingosine metabolism, Lipids chemistry, Lysophospholipids metabolism, Phosphotransferases (Alcohol Group Acceptor) chemistry, Phosphotransferases (Alcohol Group Acceptor) metabolism, Sphingosine analogs & derivatives
- Abstract
Sphingosine kinase 1 (SK1) is required for production of sphingosine-1-phosphate (S1P) and thereby regulates many cellular processes, including cellular growth, immune cell trafficking, and inflammation. To produce S1P, SK1 must access sphingosine directly from membranes. However, the molecular mechanisms underlying SK1's direct membrane interactions remain unclear. We used hydrogen/deuterium exchange MS to study interactions of SK1 with membrane vesicles. Using the CRISPR/Cas9 technique to generate HCT116 cells lacking SK1, we explored the effects of membrane interface disruption and the function of the SK1 interaction site. Disrupting the interface resulted in reduced membrane association and decreased cellular SK1 activity. Moreover, SK1-dependent signaling, including cell invasion and endocytosis, was abolished upon mutation of the membrane-binding interface. Of note, we identified a positively charged motif on SK1 that is responsible for electrostatic interactions with membranes. Furthermore, we demonstrated that SK1 uses a single contiguous interface, consisting of an electrostatic site and a hydrophobic site, to interact with membrane-associated anionic phospholipids. Altogether, these results define a composite domain in SK1 that regulates its intrinsic ability to bind membranes and indicate that this binding is critical for proper SK1 function. This work will allow for a new line of thinking for targeting SK1 in disease., (Copyright © 2018 by the American Society for Biochemistry and Molecular Biology, Inc.)
- Published
- 2018
- Full Text
- View/download PDF
48. Sphingolipids and their metabolism in physiology and disease.
- Author
-
Hannun YA and Obeid LM
- Subjects
- Aging metabolism, Animals, Apoptosis, Autophagy, Biological Transport, Active, Cell Adhesion, Cell Compartmentation, Cell Movement, DNA Damage, Enzymes metabolism, Humans, Immune System metabolism, Inflammation metabolism, Lipid Metabolism, Metabolic Diseases genetics, Metabolic Diseases metabolism, Metabolic Networks and Pathways, Models, Biological, Neoplasms metabolism, Signal Transduction, Sphingolipids chemistry, Sphingolipids physiology, Sphingolipids metabolism
- Abstract
Studies of bioactive lipids in general and sphingolipids in particular have intensified over the past several years, revealing an unprecedented and unanticipated complexity of the lipidome and its many functions, which rivals, if not exceeds, that of the genome or proteome. These results highlight critical roles for bioactive sphingolipids in most, if not all, major cell biological responses, including all major cell signalling pathways, and they link sphingolipid metabolism to key human diseases. Nevertheless, the fairly nascent field of bioactive sphingolipids still faces challenges in its biochemical and molecular underpinnings, including defining the molecular mechanisms of pathway and enzyme regulation, the study of lipid-protein interactions and the development of cellular probes, suitable biomarkers and therapeutic approaches.
- Published
- 2018
- Full Text
- View/download PDF
49. Decreased ceramide underlies mitochondrial dysfunction in Charcot-Marie-Tooth 2F.
- Author
-
Schwartz NU, Linzer RW, Truman JP, Gurevich M, Hannun YA, Senkal CE, and Obeid LM
- Subjects
- Ceramides genetics, Charcot-Marie-Tooth Disease genetics, Charcot-Marie-Tooth Disease pathology, HEK293 Cells, HSP27 Heat-Shock Proteins genetics, Humans, Membrane Proteins genetics, Mitochondria genetics, Mitochondria pathology, Sphingosine N-Acyltransferase genetics, Ceramides metabolism, Charcot-Marie-Tooth Disease metabolism, HSP27 Heat-Shock Proteins metabolism, Membrane Proteins metabolism, Mitochondria metabolism, Mutation, Sphingosine N-Acyltransferase metabolism
- Abstract
Charcot-Marie-Tooth (CMT) disease is the most commonly inherited neurologic disorder, but its molecular mechanisms remain unclear. One variant of CMT, 2F, is characterized by mutations in heat shock protein 27 (Hsp27). As bioactive sphingolipids have been implicated in neurodegenerative diseases, we sought to determine if their dysregulation is involved in CMT. Here, we show that Hsp27 knockout mice demonstrated decreases in ceramide in peripheral nerve tissue and that the disease-associated Hsp27 S135F mutant demonstrated decreases in mitochondrial ceramide. Given that Hsp27 is a chaperone protein, we examined its role in regulating ceramide synthases (CerSs), an enzyme family responsible for catalyzing generation of the sphingolipid ceramide. We determined that CerSs colocalized with Hsp27, and upon the presence of S135F mutants, CerS1 lost its colocalization with mitochondria suggesting that decreased mitochondrial ceramides result from reduced mitochondrial CerS localization rather than decreased CerS activity. Mitochondria in mutant cells appeared larger with increased interconnectivity. Furthermore, mutant cell lines demonstrated decreased mitochondrial respiratory function and increased autophagic flux. Mitochondrial structural and functional changes were recapitulated by blocking ceramide generation pharmacologically. These results suggest that mutant Hsp27 decreases mitochondrial ceramide levels, producing structural and functional changes in mitochondria leading to neuronal degeneration.-Schwartz, N. U., Linzer, R. W., Truman, J.-P., Gurevich, M., Hannun, Y. A., Senkal, C. E., Obeid, L. M. Decreased ceramide underlies mitochondrial dysfunction in Charcot-Marie-Tooth 2F.
- Published
- 2018
- Full Text
- View/download PDF
50. Correction: Alkaline Ceramidase 3 Deficiency Results in Purkinje Cell Degeneration and Cerebellar Ataxia Due to Dyshomeostasis of Sphingolipids in the Brain.
- Author
-
Wang K, Xu R, Schrandt J, Shah P, Gong YZ, Preston C, Wang L, Yi JK, Lin CL, Sun W, Spyropoulos DD, Rhee S, Li M, Zhou J, Ge S, Zhang G, Snider AJ, Hannun YA, Obeid LM, and Mao C
- Abstract
[This corrects the article DOI: 10.1371/journal.pgen.1005591.].
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.